secwatch.observer — SEC 8-K summary
======================================

Issuer:     Orthofix Medical Inc. (OFIX)
CIK:        0000884624
Form:       8-K
Filed at:   2022-12-27T23:59:59+00:00
Accession:  0001193125-22-312734
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.40
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Orthofix supplements SeaSpine merger disclosures with updated DCF and synergy projections
--------------------------------------------------------------------------------

- Perella Weinberg DCF analyses updated: discount rates 9.75%-10.75%, perpetuity growth 3.0% for synergies.
- SeaSpine standalone DCF range $2.93-$6.52 per share vs implied merger consideration $7.64 (Piper Sandler).
- Orthofix standalone DCF range $18.15-$30.17 vs Orthofix closing price $18.34.
- Piper Sandler fee estimated ~$4.3M contingent on deal closing; $1M opinion fee already paid.
- Projected cost synergies: $42M in 2025E, rising to $50M in 2031E; stock-based comp synergies $8M in 2025E.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/884624/000119312522312734/0001193125-22-312734-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/884624/000119312522312734/d398453d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-312734

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer